
    
      Assess the effect on immunogenicity of administration of vaccine without buffering agent &
      assess heat stability in terms of immunogenicity, reactogenicity & safety of GSK Biologicals'
      oral live attenuated human rotavirus (HRV) vaccine following a 0,2 m schedule, in healthy
      infants previously uninfected with human rotavirus
    
  